Page 115 - Ami News Today

Measurement of the biomarker copeptin in the ambulance may allow medics to quickly rule out myocardial infarction in patients with chest pain, randomized results of the AROMI trial suggest.

Over the course of a celebrated 40-year career, veteran Danish editor Niels Pagh Andersen...

Physicians are being forced to delay or deny patient treatments while fighting for authorization from insurers. This delay could endanger patients.

A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.

ACEN, the listed energy platform of the Ayala Group, together with its partner AMI Renewables, have reached commercial operations for its 252 MW wind

Assessing biventricular dysfunction using transthoracic echocardiography improves clinical risk stratification.

The Auckland-based edu-tech firm Kami registered a 1,177% growth in revenue since 2018, according to Deloitte.

Click here to read the full article.

When you think of Foo Fighters, do you think of… Wings? Paul McCartney does. He gave...

The strategic objective of this signing, lies in building a leading foundational base for technological innovation, both regionally and internationally. SAMI also signed an agreement with Prince Sultan Defense Studies and Science Research Center (PSDSARC), with the objective of further developing the UAV.